MCH ANALYSIS RESEARCHMain site ↗
Information Technology

Application Software

27 companies under coverage.

Coverage

Application Software


Equity Research

Bill Com Holdings Inc (BILL)

HOLD. 12-month probability-weighted target $43 (-5% vs spot). P/E Multiple explains 77% of Monte Carlo outcome variance.

BILLEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price +8.1%
Equity Research

HubSpot Inc (HUBS)

HOLD. 12-month probability-weighted target $213 (-7% vs spot). P/E Multiple explains 72% of Monte Carlo outcome variance.

HUBSEquity ResearchMonte Carlo
11 October 2026Rating: HOLD · Fair value vs price +2.3%
Equity Research

Dolby Laboratories (DLB)

SELL. 12-month probability-weighted target $49 (-16% vs spot). P/E Multiple explains 86% of Monte Carlo outcome variance.

DLBEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -1.8%
Equity Research

Ringcentral Inc (RNG)

HOLD. 12-month probability-weighted target $80 (+2% vs spot). P/E Multiple explains 62% of Monte Carlo outcome variance.

RNGEquity ResearchMonte Carlo
11 October 2026Rating: HOLD · Fair value vs price -2.1%
Equity Research

Pegasystems Inc (PEGA)

SELL. 12-month probability-weighted target $31 (-13% vs spot). P/E Multiple explains 77% of Monte Carlo outcome variance.

PEGAEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -2.3%
Equity Research

Oracle Corporation (ORCL)

HOLD. 12-month probability-weighted target $145 (+2% vs spot). P/E Multiple explains 81% of Monte Carlo outcome variance.

ORCLEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -4.5%
Equity Research

Adobe Systems Incorporated (ADBE)

SELL. 12-month probability-weighted target $198 (-18% vs spot). P/E Multiple explains 89% of Monte Carlo outcome variance.

ADBEEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -4.8%
Equity Research

Intuit Inc (INTU)

SELL. 12-month probability-weighted target $245 (-19% vs spot). P/E Multiple explains 81% of Monte Carlo outcome variance.

INTUEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -6.4%
Equity Research

Bentley Systems Inc (BSY)

HOLD. 12-month probability-weighted target $32 (-10% vs spot). P/E Multiple explains 78% of Monte Carlo outcome variance.

BSYEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -9.1%
Equity Research

Tyler Technologies Inc (TYL)

SELL. 12-month probability-weighted target $273 (-17% vs spot). P/E Multiple explains 73% of Monte Carlo outcome variance.

TYLEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -10.0%
Equity Research

Cadence Design Systems Inc (CDNS)

HOLD. 12-month probability-weighted target $372 (+5% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

CDNSEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -10.1%
Equity Research

Autodesk Inc (ADSK)

SELL. 12-month probability-weighted target $190 (-19% vs spot). P/E Multiple explains 91% of Monte Carlo outcome variance.

ADSKEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -10.1%
Equity Research

Trimble Inc (TRMB)

SELL. 12-month probability-weighted target $48 (-20% vs spot). P/E Multiple explains 74% of Monte Carlo outcome variance.

TRMBEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -14.2%
Equity Research

Guidewire Software Inc (GWRE)

SELL. 12-month probability-weighted target $147 (-12% vs spot). P/E Multiple explains 77% of Monte Carlo outcome variance.

GWREEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -17.7%
Equity Research

Dropbox Inc (DBX)

SELL. 12-month probability-weighted target $30 (-14% vs spot). P/E Multiple explains 78% of Monte Carlo outcome variance.

DBXEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -18.0%
Equity Research

Synopsys Inc (SNPS)

SELL. 12-month probability-weighted target $440 (-14% vs spot). P/E Multiple explains 82% of Monte Carlo outcome variance.

SNPSEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -20.4%
Equity Research

DocuSign Inc (DOCU)

SELL. 12-month probability-weighted target $48 (-32% vs spot). P/E Multiple explains 80% of Monte Carlo outcome variance.

DOCUEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -20.6%
Equity Research

Manhattan Associates Inc (MANH)

SELL. 12-month probability-weighted target $161 (-21% vs spot). P/E Multiple explains 80% of Monte Carlo outcome variance.

MANHEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -20.7%
Equity Research

Dynatrace Holdings LLC (DT)

SELL. 12-month probability-weighted target $44 (-30% vs spot). P/E Multiple explains 81% of Monte Carlo outcome variance.

DTEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -23.9%
Equity Research

Workday Inc (WDAY)

SELL. 12-month probability-weighted target $115 (-39% vs spot). P/E Multiple explains 78% of Monte Carlo outcome variance.

WDAYEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -29.3%
Equity Research

Salesforce.com Inc (CRM)

SELL. 12-month probability-weighted target $154 (-33% vs spot). P/E Multiple explains 80% of Monte Carlo outcome variance.

CRMEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -30.1%
Equity Research

Datadog Inc (DDOG)

SELL. 12-month probability-weighted target $232 (-21% vs spot). P/E Multiple explains 79% of Monte Carlo outcome variance.

DDOGEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -37.0%
Equity Research

PTC Inc (PTC)

SELL. 12-month probability-weighted target $114 (-41% vs spot). P/E Multiple explains 84% of Monte Carlo outcome variance.

PTCEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -37.9%
Equity Research

Palantir Technologies (PLTR)

SELL. 12-month probability-weighted target $140 (-33% vs spot). P/E Multiple explains 91% of Monte Carlo outcome variance.

PLTREquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -39.9%
Equity Research

Okta Inc (OKTA)

SELL. 12-month probability-weighted target $144 (-38% vs spot). P/E Multiple explains 76% of Monte Carlo outcome variance.

OKTAEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -41.1%
Equity Research

Appfolio Inc (APPF)

Rating suspended since 2026-09-21 — valuation input under review. The rating, price target and expected return are withheld until the name is re-valued; the research on the report page predates the review.

APPFEquity ResearchMonte Carlo
10 October 2026Rating: N/A
Equity Research

Fair Isaac Corporation (FICO)

Rating suspended since 2026-09-30 — under analyst review. The rating, price target and expected return are withheld until the name is re-valued; the research on the report page predates the review.

FICOEquity ResearchMonte Carlo
29 September 2026Rating: N/A
MCH ANALYSIS · All research · Research, not personal financial advicemchadvisoryservices.com ↗ · Research Standard v4 (decision-level) · Research OS ros-1.20.0 · US-listed

MCH Analysis is a general investment-research publication of MCH Advisory (Pty) Ltd. It is not personal financial advice and does not take your circumstances into account. MCH is not a licensed financial services provider or a registered investment adviser. Past performance, whether actual or simulated, does not predict future results. Subscriber Agreement | Privacy and Cookie Notice | Research Governance Policies